Abbott Laboratories
ABTHealth careStock · Data from SEC EDGAR 13F · Held by 18 of 87 tracked investors
Abbott Laboratories at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation34
- Growth47
- Profitability60
- Quality85
- Debt64
- Stability81
- The analysts' average target is 14% above the price.
Chart ABT
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
18MH Mason Hawkins Southeastern Asset Management | 3.98% |
Čn Česká národní banka Česká národní banka | 0.26% |
Šn Švýcarská národní banka Swiss National Bank | 0.23% |
Ns Norský státní fond Norges Bank | 0.21% |
SC Steven Cohen Point72 Asset Management | 0.16% |
CA Cliff Asness AQR Capital Management | 0.13% |
IE Israel Englander Millennium Management | 0.12% |
GI Generali Investments CEE Generali Investments CEE | 0.11% |
JG Joel Greenblatt Gotham Asset Management | 0.1% |
JS Jim Simons Renaissance Technologies | 0.09% |
KG Ken Griffin Citadel Advisors | 0.09% |
PT Paul Tudor Jones Tudor Investment Corp | 0.09% |
GS George Soros Soros Fund Management | 0.05% |
RD Ray Dalio Bridgewater Associates | 0.02% |
MG Mario Gabelli GAMCO Investors | 0.02% |
TR Thomas Russo Gardner Russo & Quinn | 0.01% |
JY Jeff Yass Susquehanna International Group | 0.01% |
KF Ken Fisher Fisher Investments | 0.01% |
Frequently asked questions
How much is Abbott Laboratories (ABT) stock?
Abbott Laboratories shares trade at $103.70, +1.16% over the last trading day. The price is delayed.
What is the market cap of Abbott Laboratories?
The market cap of Abbott Laboratories is about $179B and its price-to-earnings ratio (P/E) is 38.6.
Does Abbott Laboratories pay a dividend?
The dividend yield of Abbott Laboratories is 2.46% a year. The yield can change with the company's decisions.
How has Abbott Laboratories stock performed over the last year?
The Abbott Laboratories share price changed by -18.25% over 12 months and by -19.54% over 5 years.
Which big investors hold Abbott Laboratories?
According to the latest 13F filings, 18 of 87 tracked investors hold Abbott Laboratories, for example Mason Hawkins, Česká národní banka, Švýcarská národní banka.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.